Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience.

PURPOSE: To prospectively compare the image quality and homogeneity of magnetic resonance (MR) images obtained by using a dual-source parallel radiofrequency (RF) excitation body MR imaging system with parallel transmission and independent RF shimming with the image quality and homogeneity of single-source MR images obtained by using standard sequences for routine clinical use in patients at 3.0 T. MATERIALS AND METHODS: After institutional review board approval and informed patient consent were obtained, a dual-source parallel RF excitation 3.0-T MR system with independent RF shimming and parallel transmission technology was used to examine 28 patients and was compared with a standard 3.0-T MR system with single RF transmission. The RF power was distributed to the independent ports of the system body coil by using two RF transmission sources with full software control, enabling independent control of the phase and amplitude of the RF waveforms. Axial T2-weighted fast spin-echo (SE) and diffusion-weighted (DW) liver images, axial T2-weighted fast SE pelvic images, and sagittal T1- and T2-weighted fast SE spinal images were obtained by using dual- and single-source RF excitation. Two radiologists independently evaluated the images for homogeneity and image quality. Statistical significance was calculated by using the nonparametric Wilcoxon signed rank test. Interobserver agreement was determined by using Cohen kappa and Kendall tau-b tests. RESULTS: Image quality comparisons revealed significantly better results with dual-source rather than single-source RF excitation at T2-weighted liver MR imaging (P = .001, kappa = 1.00) and better results at DW liver imaging at a statistical trend level (P = .066, tau-b > 0.7). Owing to reduced local energy deposition, fewer acquisitions and shorter repetition times could be implemented with dual-source RF excitation pelvic and spinal MR imaging, with image acquisition accelerating by 18%, 33%, and 50% compared with the acquisitions with single-source RF excitation. Image quality did not differ significantly between the two MR techniques (P > .05, tau-b > 0.5). CONCLUSION: Dual-source parallel RF excitation body MR imaging enables reduced dielectric shading, improved homogeneity of the RF magnetic induction field, and accelerated imaging at 3.0 T.

Dynamic pelvic floor MR imaging at 3 T in patients with clinical signs of urinary incontinence-preliminary results.

To prospectively evaluate feasibility, image quality and diagnostic accuracy of dynamic MR imaging the pelvic floor at 3.0 T in patients with urinary incontinence and to compare these results with those of MRI performed at 1.5 T. Ten patients with the diagnosis of urinary incontinence (clinical symptoms, clinical examination, pelvic ultrasound) were examined with a dynamic balanced FFE (B-FFE) sequence at 1.5 T and 3.0 T on the same day in a randomized order. Spatial (1.5 x 1.5 x 8 mm) and temporal (0.44 s) resolution at 3.0 T were comparable to the 1.5-T B-FFE sequence. Two radiologists assessed visual signal to noise (three-point scale), artefact level (five-point scale) and final MR diagnoses with regard to pelvic floor weakness (independent analysis). The diagnoses obtained at 1.5-T field strength and the results of the clinical tests served as standard of reference. In addition, ROI-based quantitative measurements were performed to assess different tissue contrasts at both field strengths. Data were analyzed for statistical differences by using the Wilcoxon's matched pairs test and the marginal homogeneity test. Visual signal to noise was rated higher at 3.0 T for all ten studies by both radiologists. With regard to artefact level, there was no statistically significant difference between the studies obtained at 3.0 T as compared to the corresponding 1.5-T studies (marginal homogeneity test: p = 0.18 for reviewer 1 and 0.41 for reviewer 2). Mean artefact level was rated minor to moderate by both reviewers for both field strengths (excellent interobserver agreement with Kendall-W value of 0.973). Except for a higher tissue contrast between fat and urethra at 1.5 T, there were no statistically significant differences between tissue contrast at 1.5 T as compared to 3.0 T (Wilcoxon's test). Final MR diagnoses regarding pelvic floor weakness did not differ between 3.0-T and 1.5-T field strength and correlated well with the results of the clinical tests. Dynamic pelvic floor MR imaging is feasible at 3.0 T. Our preliminary data indicate that evaluation of pelvic floor disease seems to be possible with 3.0 T equally well as compared to 1.5 T.

Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part II. Technical considerations and clinical applications.

This is the second part of a two-part series on the clinical applications of high-field-strength (3.0-T) magnetic resonance (MR) imaging and spectroscopy. In this part, the current level of evidence regarding the use of higher magnetic field strengths for cardiac imaging techniques (including the assessment of cardiac anatomy and function), breast and pelvic imaging, musculoskeletal applications, pediatric imaging, and MR spectroscopy is presented. Published data are interpreted from the perspective of the clinical radiologist. Specific difficulties associated with high-field-strength MR for body imaging and for spectroscopic applications are reviewed and compared with the expected or documented added value of high-field-strength MR for clinical patient care. The overall number of studies published on clinical body high-field-strength MR is still small, and there is evidence for a clinical advantage for selected, but not all, body MR imaging applications. Even without published evidence, clinical experience suggests substantial clinical advantages for musculoskeletal and pediatric applications.

Female pelvis: MR imaging at 3.0 T with sensitivity encoding and flip-angle sweep technique.

This study had institutional review board approval; all 33 patients (mean age, 47 years +/- 16 [standard deviation]) gave informed consent. The aim was to prospectively evaluate the diagnostic image quality yielded by a 3.0-T T2-weighted turbo spin-echo magnetic resonance imaging sequence with a very short imaging time versus that yielded by a standard 3.0-T sequence at imaging of the female pelvis. Signal-to-noise ratio and delineation of gynecologic disorders were approximately equal between the two sequences. The majority of tissue contrasts were comparable, but contrast between fluid and muscle was significantly higher and motion artifacts were reduced (P < .001 for both) with the short imaging time sequence. The fast sequence maintained or improved image quality and thus seems to be advantageous for uncooperative patients.

High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.

PURPOSE: To prospectively evaluate whether magnetic resonance (MR) imaging of the liver at 3.0 T is comparable to that at 1.5 T with respect to image artifacts, image quality, and diagnostic utility in terms of detection and characterization of focal liver lesions in patients with these lesions. MATERIALS AND METHODS: Patients provided informed consent after the study had been explained, and the institutional review board approved the study protocol. An intraindividual comparative study was performed in 21 patients (12 men and nine women; mean age, 58.7 years; range, 36-76 years) with a total of 79 focal liver lesions (benign and malignant) who were examined at 1.5- and 3.0-T MR imaging within 1 week. The imaging protocol consisted of T2-weighted turbo spin-echo (SE) sequences with or without fat suppression, as well as T1-weighted gradient-echo (GRE) sequences with or without gadolinium-based contrast agent. All images were rated independently by two radiologists with respect to types of artifacts (susceptibility, motion, pulsation, image homogeneity, and electrodynamic effects) and in regard to detectability and characterization of focal liver lesions. A modified sign test was used for statistical analysis (alpha < .2). RESULTS: Motion artifacts were significantly more pronounced in non-fat-suppressed T2-weighted turbo SE images at 3.0 T (P = .03), whereas pulsation artifacts were more pronounced (P = .19) in precontrast T1-weighted GRE 1.5-T images. No statistically significant differences (P < .2) were observed for the remaining artifacts and sequences. Of the 79 index lesions, a total of 76 were prospectively identified at 1.5-T imaging and a total of 77 were identified at 3.0-T imaging. CONCLUSION: MR imaging of the liver at 3.0 T, compared with that at 1.5 T, is feasible with equivalent image quality and diagnostic utility in terms of detection and characterization of focal liver lesions.

Dynamic contrast-enhanced breast MR imaging in men: preliminary results.

PURPOSE: To prospectively evaluate whether the descriptors of lesion features and the diagnostic criteria that have been established for breast magnetic resonance (MR) imaging in female patients may be used for differential diagnosis with breast MR imaging in male patients as well. MATERIALS AND METHODS: The study design was approved by the institutional review board; all patients gave informed consent. The Institutional Review Board and informed consent information applied to the prospective and any retrospective component of the study. Seventeen consecutive male patients (mean age, 53 years +/- 14) were referred for imaging of a palpable breast mass. In addition to mammography and high-frequency breast ultrasonography, patients underwent dynamic breast MR imaging in a prone position with a dedicated double-breast surface coil. The standardized protocol consisted of a T2-weighted turbo spin-echo sequence followed by a dynamic series. Findings were recorded by using the terminology and descriptors and by evaluating the diagnostic criteria (related to morphology and enhancement kinetics) that have been developed for breast MR imaging in female patients. Validation was achieved at biopsy (nine patients) or follow-up with clinical examination and conventional imaging (eight patients). Because of the small size of the patient cohort, statistical significance was not tested. RESULTS: A total of 24 breast abnormalities were diagnosed. Three patients had invasive breast cancer (five tumors), 11 had gynecomastia (six unilateral, five bilateral), two had pseudogynecomastia, and one had a benign solid tumor (angiolipoma). All malignant tumors appeared as irregular masses with heterogeneous internal architecture or rim enhancement and showed rapid initial enhancement (mean value, 137% +/- 23) followed by a washout time course (Breast Imaging Reporting and Data System [BI-RADS] category 5). Diffuse and nodular gynecomastia showed slow initial and persistent enhancement with normal-appearing parenchymal architecture (BI-RADS category 2; 15 of 16 breasts in 10 of 11 patients). In one patient with biopsy-proved bilateral gynecomastia, an area with segmental enhancement was classified as suspicious for ductal carcinoma in situ. Pseudogynecomastia did not enhance at all. The angiolipoma showed benign morphologic features and slow initial and persistent enhancement (BI-RADS category 2). CONCLUSION: In the small study cohort, the MR imaging features of benign breast diseases and breast cancers in male patients seemed to be comparable to those seen in female patients.

MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time.

OBJECTIVE: The higher signal at 3.0-T allows spatial resolution to be increased without loss in image quality. We evaluated a T2-weighted turbo spin-echo sequence with high spatial resolution (3T-HR) to determine whether this provides clinically useful pelvic MRI. MATERIALS AND METHODS: We designed a sequence with high spatial resolution (3T-HR) (0.45x0.46x4 mm) that was combined with parallel imaging and the variable refocusing angle technique (8.06 min). We examined 23 patients with gynecological disorders using 3T-HR and a standard sequence (3T-SP; 4.03 min; equivalent to 1.5 T). Two radiologists analyzed tissue contrast, signal to noise, detail delineation and artifact level. RESULTS: Tissue contrasts and signal to noise were rated equal. Motion artifacts occurred more often with 3T-SP despite the longer scanning time of 3T-HR. The higher spatial resolution provided additional information in four patients. In two patients small myomas were detected, in one patient a lymph node metastasis was apparent, and in one patient 3T-HR excluded tumor invasion. CONCLUSIONS: High spatial resolution pelvic studies with high image quality can be obtained at 3 T in acceptable scan time. The higher spatial resolution that is feasible at 3 T also provides more clinically relevant information.

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

PURPOSE: To compare the effectiveness of mammography, breast ultrasound, and magnetic resonance imaging (MRI) for surveillance of women at increased familial risk for breast cancer (lifetime risk of 20% or more). PATIENTS AND METHODS: We conducted a surveillance cohort study of 529 asymptomatic women who, based on their family history and/or mutational analysis, were suspected or proven to carry a breast cancer susceptibility gene (BRCA). A total of 1,542 annual surveillance rounds were completed with a mean follow-up of 5.3 years. Diagnostic accuracies of the three imaging modalities used alone or in different combinations were compared. RESULTS: Forty-three breast cancers were identified in the total cohort (34 invasive, nine ductal carcinoma-in-situ). Overall sensitivity of diagnostic imaging was 93% (40 of 43 breast cancers); overall node-positive rate was 16%, and one interval cancer occurred (one of 43 cancers, or 2%). In the analysis by modality, sensitivity was low for mammography (33%) and ultrasound (40%) or the combination of both (49%). MRI offered a significantly higher sensitivity (91%). The sensitivity of mammography in the higher risk groups was 25%, compared with 100% for MRI. Specificity of MRI (97.2%) was equivalent to that of mammography (96.8%). CONCLUSION: Mammography alone, and also mammography combined with breast ultrasound, seems insufficient for early diagnosis of breast cancer in women who are at increased familial risk with or without documented BRCA mutation. If MRI is used for surveillance, diagnosis of intraductal and invasive familial or hereditary cancer is achieved with a significantly higher sensitivity and at a more favorable stage.